JPS627169B2 - - Google Patents
Info
- Publication number
- JPS627169B2 JPS627169B2 JP52156546A JP15654677A JPS627169B2 JP S627169 B2 JPS627169 B2 JP S627169B2 JP 52156546 A JP52156546 A JP 52156546A JP 15654677 A JP15654677 A JP 15654677A JP S627169 B2 JPS627169 B2 JP S627169B2
- Authority
- JP
- Japan
- Prior art keywords
- activated carbon
- spherical
- constipation
- charcoal
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 79
- 230000000694 effects Effects 0.000 claims description 22
- 206010010774 Constipation Diseases 0.000 claims description 20
- 239000011148 porous material Substances 0.000 claims description 8
- 239000000729 antidote Substances 0.000 claims description 3
- 239000003610 charcoal Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000001784 detoxification Methods 0.000 description 5
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 210000002249 digestive system Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 239000012798 spherical particle Substances 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 2
- 229960000511 lactulose Drugs 0.000 description 2
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QHGUCRYDKWKLMG-QMMMGPOBSA-N (R)-octopamine Chemical compound NC[C@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-QMMMGPOBSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000022540 Consciousness disease Diseases 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- QHGUCRYDKWKLMG-MRVPVSSYSA-N Octopamine Natural products NC[C@@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-MRVPVSSYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229940082079 activated charcoal / magnesium hydroxide Drugs 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000005539 carbonized material Substances 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- -1 etc. Substances 0.000 description 1
- 238000002146 exchange transfusion Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229940105082 medicinal charcoal Drugs 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960001576 octopamine Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000013094 purity test Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Carbon And Carbon Compounds (AREA)
- External Artificial Organs (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15654677A JPS5489010A (en) | 1977-12-27 | 1977-12-27 | Spherical activated charcoal antidote |
CA318,549A CA1112172A (en) | 1977-12-27 | 1978-12-22 | Antidote consisting of particles of activated carbon |
GB7849806A GB2012257B (en) | 1977-12-27 | 1978-12-22 | Particles of activated carbon and their use in combatting gastrointrstinal illnesses |
DE2855825A DE2855825C2 (de) | 1977-12-27 | 1978-12-22 | Verwendung von Aktivkohleteilchen als Antidot |
ES476321A ES476321A1 (es) | 1977-12-27 | 1978-12-26 | Mejoras en la preparacion de antidotos cosistentes en parti-culas de carbono activado. |
FR7836293A FR2413092A1 (fr) | 1977-12-27 | 1978-12-26 | Produit a base de particules de charbon actif et son application en tant qu'antidote |
NL7812550A NL7812550A (nl) | 1977-12-27 | 1978-12-27 | Actieve kool als tegengif. |
US06/759,933 US4761284A (en) | 1977-12-27 | 1985-07-29 | Antidote including activated carbon particles |
US07/047,291 US4822765A (en) | 1977-12-27 | 1987-05-08 | Process for treating activated carbon with aqueous ammonia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15654677A JPS5489010A (en) | 1977-12-27 | 1977-12-27 | Spherical activated charcoal antidote |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5489010A JPS5489010A (en) | 1979-07-14 |
JPS627169B2 true JPS627169B2 (da) | 1987-02-16 |
Family
ID=15630152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15654677A Granted JPS5489010A (en) | 1977-12-27 | 1977-12-27 | Spherical activated charcoal antidote |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS5489010A (da) |
CA (1) | CA1112172A (da) |
DE (1) | DE2855825C2 (da) |
ES (1) | ES476321A1 (da) |
FR (1) | FR2413092A1 (da) |
GB (1) | GB2012257B (da) |
NL (1) | NL7812550A (da) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4761284A (en) * | 1977-12-27 | 1988-08-02 | Kureha Kagaku Kogy Kabushiki Kaisha | Antidote including activated carbon particles |
JPS565313A (en) * | 1979-06-26 | 1981-01-20 | Kureha Chem Ind Co Ltd | Detoxificating spherical active carbon and preparing the same |
JPS5673542A (en) * | 1979-11-22 | 1981-06-18 | Kureha Chem Ind Co Ltd | Adsorbent |
JPS5731864A (en) * | 1980-08-04 | 1982-02-20 | Teijin Ltd | Oral activated carbon microcapsule |
DE3819000A1 (de) * | 1988-06-03 | 1989-12-14 | Hasso Von Bluecher | Beutel in der art eines teebeutels zur beseitigung von schadstoffen |
IT1273678B (it) * | 1993-08-12 | 1997-07-09 | Bluecher Hasso Von | Processo per la produzione di carbone attivo |
NL1000078C2 (nl) * | 1994-04-19 | 1996-04-22 | Bluecher Hasso Von | Geurfilter voor stofzuigers. |
SE515506C2 (sv) * | 1994-06-17 | 2001-08-20 | Mhb Filtration Gmbh & Co Kg | Luktfilter för ventilationsutloppshuvar |
SE509743C2 (sv) * | 1994-06-17 | 1999-03-01 | Bluecher Hasso Von | Adsorptionsfilterskikt |
FR2745981B1 (fr) * | 1996-03-15 | 1998-06-05 | Agent adsorbant diminuant ou eliminant les effets secondaires lies a l'absorption d'agents edulcorants | |
JPH1129485A (ja) * | 1997-07-10 | 1999-02-02 | Kureha Chem Ind Co Ltd | 抗肥満剤 |
JP3522708B2 (ja) * | 2001-04-11 | 2004-04-26 | 呉羽化学工業株式会社 | 経口投与用吸着剤 |
KR100680449B1 (ko) * | 2002-11-01 | 2007-02-08 | 가부시키가이샤 쿠레하 | 경구투여용 흡착제 |
US7651974B2 (en) | 2002-11-01 | 2010-01-26 | Kureha Chemical Industry Co., Ltd. | Adsorbent for oral administration |
CN1615908B (zh) * | 2003-10-22 | 2011-09-28 | 株式会社吴羽 | 口服给药用吸附剂、以及肾病治疗或预防剂、和肝病治疗或预防剂 |
TWI370012B (en) | 2004-04-02 | 2012-08-11 | Kureha Corp | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
TWI370013B (en) | 2004-04-02 | 2012-08-11 | Kureha Corp | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
WO2005115611A1 (ja) * | 2004-05-31 | 2005-12-08 | Teikoku Medix Co., Ltd. | 吸着剤およびその製造法 |
CN1964727A (zh) * | 2004-06-02 | 2007-05-16 | 株式会社吴羽 | 循环器官功能障碍因子除去剂 |
US8247072B2 (en) | 2006-02-14 | 2012-08-21 | Eastman Chemical Company | Resol beads, methods of making them and methods of using them |
EP2120861A2 (en) * | 2006-11-27 | 2009-11-25 | De Novo Inc. | Decontaminant edible product, methods of production and uses thereof |
JP5984352B2 (ja) * | 2010-10-12 | 2016-09-06 | フタムラ化学株式会社 | 経口投与用医薬用吸着剤の製造方法 |
JP5985027B2 (ja) * | 2010-10-12 | 2016-09-06 | フタムラ化学株式会社 | 経口投与用医薬用吸着剤の製造方法 |
WO2014044794A2 (en) | 2012-09-21 | 2014-03-27 | Ferring Bv | Pharmaceutical composition |
EP2978413A1 (en) | 2013-03-25 | 2016-02-03 | Ferring BV | Composition for the treatment of disease |
KR101924201B1 (ko) * | 2014-02-07 | 2018-12-03 | 대원제약주식회사 | 강도가 증가된 경구 투여형 의약용 흡착제 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4983690A (da) * | 1972-12-20 | 1974-08-12 | ||
JPS49126591A (da) * | 1973-04-10 | 1974-12-04 | ||
JPS5018879A (da) * | 1973-06-20 | 1975-02-27 | ||
JPS5051996A (da) * | 1973-09-11 | 1975-05-09 | ||
JPS51148291A (en) * | 1975-06-13 | 1976-12-20 | Teijin Ltd | Artificial organ |
JPS51151693A (en) * | 1975-06-23 | 1976-12-27 | Eisai Co Ltd | Coated bead-like activated carbon for blood purification |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5018879B2 (da) * | 1971-08-27 | 1975-07-02 | ||
DE2410372C2 (de) * | 1974-03-05 | 1982-03-04 | Kureha Kagaku Kogyo K.K., Tokyo | Verfahren zum Reaktivieren von verbrauchter praktisch kugelförmiger Aktivkohle kleiner Größe |
-
1977
- 1977-12-27 JP JP15654677A patent/JPS5489010A/ja active Granted
-
1978
- 1978-12-22 DE DE2855825A patent/DE2855825C2/de not_active Expired
- 1978-12-22 CA CA318,549A patent/CA1112172A/en not_active Expired
- 1978-12-22 GB GB7849806A patent/GB2012257B/en not_active Expired
- 1978-12-26 FR FR7836293A patent/FR2413092A1/fr active Granted
- 1978-12-26 ES ES476321A patent/ES476321A1/es not_active Expired
- 1978-12-27 NL NL7812550A patent/NL7812550A/xx active Search and Examination
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4983690A (da) * | 1972-12-20 | 1974-08-12 | ||
JPS49126591A (da) * | 1973-04-10 | 1974-12-04 | ||
JPS5018879A (da) * | 1973-06-20 | 1975-02-27 | ||
JPS5051996A (da) * | 1973-09-11 | 1975-05-09 | ||
JPS51148291A (en) * | 1975-06-13 | 1976-12-20 | Teijin Ltd | Artificial organ |
JPS51151693A (en) * | 1975-06-23 | 1976-12-27 | Eisai Co Ltd | Coated bead-like activated carbon for blood purification |
Also Published As
Publication number | Publication date |
---|---|
GB2012257B (en) | 1983-03-30 |
JPS5489010A (en) | 1979-07-14 |
FR2413092A1 (fr) | 1979-07-27 |
DE2855825A1 (de) | 1979-06-28 |
ES476321A1 (es) | 1979-06-16 |
DE2855825C2 (de) | 1984-03-01 |
FR2413092B1 (da) | 1982-11-19 |
NL7812550A (nl) | 1979-06-29 |
GB2012257A (en) | 1979-07-25 |
CA1112172A (en) | 1981-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS627169B2 (da) | ||
JPS6229368B2 (da) | ||
US4822765A (en) | Process for treating activated carbon with aqueous ammonia | |
US4681764A (en) | Porous and spherical carbonaceous product | |
EP2222314B1 (en) | Uses and means for otaining bronchorelaxation | |
TWI319985B (en) | Adsorbent for oral administration, agent for treating or preventing renal disease, and agent for treating or preventing liver disease | |
ES2259981T3 (es) | Composicion laxante que contiene simeticona. | |
KR100335023B1 (ko) | 염증성장질환치료용약제학적조성물 | |
US20100272814A1 (en) | Method and means for producing bronchorelaxation | |
KR970002613B1 (ko) | 항네프로제증후군제 | |
JP3338119B2 (ja) | 抗糖尿病剤 | |
JPH0729916B2 (ja) | 鎮痛性を有する医薬組成物 | |
JPH1129485A (ja) | 抗肥満剤 | |
EP0688566B1 (en) | Use of spherical activated carbon for the treatment of hemorrhoidal diseases | |
JPS6360009B2 (da) | ||
JPH0142927B2 (da) | ||
US20130209581A1 (en) | Iodinated activated charcoal for treating symptoms of depression | |
JP2799553B2 (ja) | 抗痔疾患剤 | |
KR820000684B1 (ko) | 활성탄 입자로 된 해독제의 제조방법 | |
KR840001449B1 (ko) | 다공성 구상 탄소질 생성물의 제조방법 | |
EP2723352A1 (en) | Activated carbon and iodine/iodine salts for treating chronic fatigue syndrome | |
US2991225A (en) | Omicron-methylbenzhydryl-beta-dimethylaminoethyl ether process and composition for symptomatic relief of the syndrome of parkinsonism and of spastic skeletal muscle disorders | |
EP0264430A1 (en) | Composition and method for reducing blood alcohol content | |
WO2015119352A1 (ko) | 강도가 증가된 경구 투여형 의약용 흡착제 | |
JPH0466530A (ja) | 3―オキシゲルミルプロピオン酸作用安定化錠剤及び該錠剤の組成物を主成分とする風邪症侯群治療剤 |